222
Views
8
CrossRef citations to date
0
Altmetric
Review Articles

Molecular and epigenetic modes of Fumonisin B1 mediated toxicity and carcinogenesis and detoxification strategies

ORCID Icon, ORCID Icon & ORCID Icon
Pages 76-94 | Received 22 Oct 2020, Accepted 21 Jan 2021, Published online: 19 Feb 2021
 

Abstract

Fumonisin B1 (FB1) is a natural contaminant of agricultural commodities that has displayed a myriad of toxicities in animals. Moreover, it is known to be a hepatorenal carcinogen in rodents and may be associated with oesophageal and hepatocellular carcinomas in humans. The most well elucidated mode of FB1-mediated toxicity is its disruption of sphingolipid metabolism; however, enhanced oxidative stress, endoplasmic reticulum stress, autophagy, and alterations in immune response may also play a role in its toxicity and carcinogenicity. Alterations to the host epigenome may impact on the toxic and carcinogenic response to FB1. Seeing that the contamination of FB1 in food poses a considerable risk to human and animal health, a great deal of research has focused on new methods to prevent and attenuate FB1-induced toxic consequences. The focus of the present review is on the molecular and epigenetic interactions of FB1 as well as recent research involving FB1 detoxification.

Acknowledgements

The authors gratefully acknowledge Dr. Pragalathan Naidoo, University of KwaZulu-Natal, South Africa, for critical proofreading of the manuscript. The authors note with appreciation the value of four sets of comments and critiques provided by reviewers selected by the Editor and anonymous to the authors.

Declaration of interest

The authors declare to have no conflict of interest. The authors acknowledge the National Research Foundation (NRF) of South Africa for funding this review. The review was conceptualized by the authors and represents an unbiased professional assessment of available literature. The conclusions drawn are exclusively those of the authors. None of the authors have appeared during the last 10 years in any regulatory or legal proceedings related to the contents of this paper. We thank the NRF (Grant number 120820).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.